PRURIGO NODULARIS (PN)
Clinical trials for PRURIGO NODULARIS (PN) explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS (PN) trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS (PN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks Dupilumab's Long-Term impact on chronic itch condition
Disease control Recruiting nowThis study follows 40 adults with moderate-to-severe prurigo nodularis who are starting dupilumab (Dupixent). Researchers will track how well the drug controls itching and skin lesions over time, and also study changes in immune cells and proteins in the skin and blood. The goal …
Matched conditions: PRURIGO NODULARIS (PN)
Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New pill could stop the maddening itch of prurigo nodularis
Symptom relief Recruiting nowThis study tests an experimental drug called ICP-332 for people with prurigo nodularis, a skin condition causing many intensely itchy bumps. About 135 adults will receive either the drug or a placebo to see if it reduces itching and clears the bumps over 16 weeks. The goal is to …
Matched conditions: PRURIGO NODULARIS (PN)
Phase: PHASE2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC